Interleukin-2-Based Immunotherapy and Chemoimmunotherapy in Metastatic Melanoma-Reference-Cited by-同舟云学术

Interleukin-2-Based Immunotherapy and Chemoimmunotherapy in Metastatic Melanoma

Published:1995 Issue: Volume: Page:383-390
ISSN:0080-0015
Container-title:Recent Results in Cancer Research
language:
Short-container-title:

Author:

Keilholz U.,Scheibenbogen C.,Brossart P.,Möhler T.,Tilgen W.,Hunstein W.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-78771-3_29.pdf

Reference33 articles.

1. Bergmann L, Weidmann E, PS Mitrou, Runne U, Keilholz U, Bartsch HH et al (1990) Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II study. Onkologie 13:137–140

2. Bukowski RM, Murthy S, Sergi J, Budd GT, McKeever S, Medendorp SV et al (1990) Phase I trial of continuous infusion recombinant interleukin-2 and intermit-tant recombinant interferon.a2a: clinical effects. J Biol Response Mod 9:538–545

3. Comis RL (1976) DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep 64:1123

4. Demchak PA, Mier JW, Robert NJ, O’Brien K, Gould JA, Atkins MB (1991) Interleukin-2 and high dose cisplatin in patients with metastatic melanoma: a pilot study. J Clin Oncol 9:1821–1830

5. Dummer R, Becker JC, Kalhammer U, Michaelis A, Ostmeier H, Tschammler A, Hartmann AA, Burg G (1991) Combined chemo- and immunotherapy using dacarbazine and continuous infusion of interleukin 2 in metastatic malignant melanoma. Results of a phase II clinical trial. Eur J Dermatol 1:201–205

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment for metastatic malignant melanoma: Old drugs and new strategies;Critical Reviews in Oncology/Hematology;2010-04

2. Cutaneous Malignant Melanoma;Managing Skin Cancer;2010

3. The role of biological response modifiers in malignant melanoma;Expert Opinion on Biological Therapy;2003-12

4. Immunology and immunotherapy of human cancer: present concepts and clinical developments;Critical Reviews in Oncology/Hematology;2000-04

5. IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA;Hematology/Oncology Clinics of North America;1998-08